Good for M&A, Bad for ACA? Experts Predict Trump’s Impact on Health Insurers

  • Nov 08, 2024

    With Donald Trump declared the winner of the 2024 presidential election and Republicans controlling at least one chamber of Congress, experts are divided about the myriad ways in which the new balance of power in Washington might affect health insurers. Yet they largely agree on one subject: The Biden administration’s intense scrutiny of health care deals likely won’t be shared by the second Trump regime. 

    “The biggest thing is a more permissive antitrust regime, where mergers & acquisitions are going to be allowed,” says Dan Mendelson, CEO of Morgan Health, founder of the consultancy Avalere Health and a former health official in the Clinton administration.  

    Read more
    © 2024 MMIT
  • Leslie Small

    Leslie has been working in journalism since 2009 and reporting on the health care industry since 2014. She has covered the many ups and downs of the Affordable Care Act exchanges, the failed health insurer mega-mergers, and hundreds of other storylines spanning subjects such as Medicaid managed care, Medicare Advantage, employer-sponsored insurance, and prescription drug coverage. As the managing editor of Health Plan Weekly and Radar on Drug Benefits, she writes and edits for both publications while overseeing a small team of reporters who also focus on the managed care sector. Before joining AIS Health, she was a senior editor for the e-newsletter Fierce Health Payer, and she started her career as a copy editor at multiple local newspapers. She graduated with a dual degree in journalism and political science from Penn State University.

The Latest
Meet Our Reporters

Meet Our Reporters

×
×